Effect of rosiglitazone on aquaporin-1 expression in human peritoneal mesothelial cells and human umbilical vein endothelial cells

HUANG Cong-yang,ZHANG Xiao-juan,YAO Qiang,DAI Hui-li,NI Zhao-hui

DOI: https://doi.org/10.3969/j.issn.1671-4091.2009.02.008

2009-01-01

Abstract:Objective To study the effect of rosiglitazone(RGZ),a ligand of peroxisome proliferator-activated receptorγ(PPAR-γ),on the cell-proliferation and expression of aquaporin-1 mRNA in human peritoneal mesothelial cells(HPMCs) and human umbilical vein endothelial cells(HUVECs) in vitro.Methods Each kind of cells were divided into 4 groups:the control group,the RGZ group(10ìM RGZ),the GW9662 group(GW9662,a PPAR-γ antagonist,20ìM) and the GW9662+RGZ group(cells were cultured for 1 h in the medium containing 20μM GW9662 and then in the medium containing 10μM RGZ).Cell-proliferation affected by RGZ was assayed by using a CCK-8 cell-counting kit.Aquaporin-1 mRNA in HPMCs and HUVECs was measured by quantitative real-time PCR.Results Proliferation of HPMCs was inhibited in the GW9662+RGZ group(P<0.01) as com-pared with that of the control group.The inhibition was not found in the RGZ group and the GW9662 group(P> 0.05).However,proliferation of HUVECs presented in the 3 treated groups(P<0.01).RGZ up-regulated aquaporin-1 mRNA in HPMCs and HUVECs.Conclusion RGZ can up-regulate the expression of aquaporin-1 at the mRNA level,probably through the activation of the PPARγ pathway in HPMCs and HUVECs.